Filter by last updated date
Showing 1 to 10 of 338
| Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
|---|---|---|---|---|---|---|
| Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal) | Reference number:TA452 | TA00452 | Published:July 2017 | 20170701 | Last updated:July 2017 | 20170705 |
| Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal) | Reference number:TA453 | TA00453 | Published:July 2017 | 20170701 | Last updated:July 2017 | 20170705 |
| Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | Reference number:TA454 | TA00454 | Published:July 2017 | 20170701 | Last updated:July 2017 | 20170705 |
| Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma | Reference number:TA446 | TA00446 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer | Reference number:TA447 | TA00447 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Etelcalcetide for treating secondary hyperparathyroidism | Reference number:TA448 | TA00448 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease | Reference number:TA449 | TA00449 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia | Reference number:TA450 | TA00450 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia | Reference number:TA451 | TA00451 | Published:June 2017 | 20170601 | Last updated:June 2017 | 20170628 |
| Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal) | Reference number:TA444 | TA00444 | Published:May 2017 | 20170501 | Last updated:May 2017 | 20170524 |